Best of Hematology and Breast Cancer 2025, Tucson

Tucson, AZ US
September 13, 2025

The Best of Hematology and Breast Cancer 2025 conference in Tucson is a CME-accredited, in-person event that brings together leading experts and frontline clinicians to explore the latest advancements in the diagnosis and management of hematologic malignancies and breast cancer.

This highly interactive conference emphasizes translating innovation into practice, combining evidence-based didactic sessions with expert panel discussions that address real-world clinical challenges. Faculty will review and interpret the most impactful clinical data, updated guidelines, and novel therapies shaping the current standard of care.

Designed for oncologists, hematologists, advanced practice providers, pharmacists, nurses, and other oncology professionals, this program fosters critical thinking, peer engagement, and the practical application of emerging science to improve patient outcomes.

The Best of Hematology and Breast Cancer 2025, Tucson, is an educational activity planned by the Binaytara Foundation. Neither Binaytara Foundation nor this activity are affiliated with the American Society of Hematology (ASH) or the San Antonio Breast Cancer Symposium (SABCS).

Target Audience

  • Medical Oncologists
  • Surgical Oncologists
  • Radiation Oncologists
  • Oncology Fellows
  • Oncology Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Oncology Pharmacists

Organizing Committee

Conference Director:

  • Binay Shah, MD, MHA - Binaytara

Conference Chair:

  • Sharad Khurana, MD, MSc - University of Arizona Cancer Center 
  • Sima Ehsani, MD - University of Arizona Cancer Center

Planning Committee:

  • Abhinav Chandra, MD, MSc, FACP, MBA - Onvida Health Cancer Center

Learning Objectives

By the end of this activity, participants will be able to:

  • Summarize recent clinical advancements and evolving standards in the management of hematologic disorders and breast cancer.
  • Evaluate newly approved and emerging therapies, including their mechanisms of action, indications, and contraindications in clinical practice.
  • Interpret clinical trial data, study design, and endpoints relevant to practice-changing therapies in hematology and breast oncology.
  • Apply current guidelines and evidence-based strategies to personalize diagnosis, prognosis, and treatment for patients with hematologic disorders and breast cancer.

You may also be interested in

2025 Summit on Hematologic Cancers

This CME/CPE-accredited activity, the 2025 Summit on Hematologic Cancers, is a national meeting featuring leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of acute myeloid

5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

The 5th Binaytara Precision Oncology Summit is a two-day, CME-accredited national conference bringing together leading experts and oncology professionals to explore cutting-edge developments in precision oncology.
Course summary
Available credit: 
  • 7.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 7.25 ACPE Pharmacy

    The Binaytara Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    The ACPE Universal Activity Number assigned to the activity is

    Participants must pass the post-test, complete course evaluation, and provide their NABP e-Profile ID number (ePID) and Date of Birth (MMDD) to Binaytara Foundation within 30-days of participating in the activity. Participants who do not complete these requirements within 30-days of participating in the Live activity will not be awarded the CEUs.

    The Binaytara foundation may distribute a participation certificate containing information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.

    After CPE units are processed by ACPE and NABP, pharmacists and pharmacy technicians will be able to login to a comprehensive electronic profile to access information about their completed CPE and Certificate Programs.

    ACPE Pharmacy
  • 7.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.
Course opens: 
04/02/2025
Course expires: 
12/13/2025
Event starts: 
09/13/2025 - 8:00am PDT
Event ends: 
09/13/2025 - 5:10pm PDT
Cost:
$150.00
Add to calendar: 

Saturday, September 13, 2025

All times listed in Mountain Time (MT)

07:00 AM – 08:00 AM  Registration, Exhibits & Breakfast

08:00 AM – 08:05 AM  Welcome

08:05 AM – 08:30 AM  Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA

08:30 AM – 09:10 AM  Session 1: Tumor Board-Style Case-Based Discussion: Benign Hematology

Session Chair:

08:30 AM – 08:50 AM  TTP-HUS - Hemant Sindhu, MD

08:50 AM – 09:10 AM  Hemophilia - Akshay Amaraneni, MD

09:10 AM – 10:25 AM  Session 2: Acquired Bone Marrow Failure Syndromes

Session Chair: Jaspreet Chahal, MD

09:10 AM – 09:40 AM  PNH

09:40 AM – 10:10 AM  Aplastic Anemia/Marrow Failure Syndromes

10:10 AM – 10:25 AM  Panel discussion

10:25 AM – 10:45 AM  Break & Exhibits

10:45 AM – 12:15 PM  Session 3: Leukemia

Session Chair: Matthew Ulrickson, MD

10:45 AM – 11:15 AM  Acute Leukemia and MDS

11:15 AM – 11:45 PM  Chronic Leukemia and CLL

11:45 AM – 12:15 PM  Panel discussion

12:15 PM – 01:15 PM  Lunch & Exhibits

01:15 PM – 02:15 PM  Session 4: Lymphoid Malignancies

Session Chair: Krishna Moturi, MD & Sumit Madan, MD

01:15 PM – 01:45 PM  Multiple Myeloma

01:45 PM – 02:15 PM  Lymphoma - Abhijeet Kumar, MD

02:15 PM – 03:15 PM  Session 5: Hematologic Malignancies

Session Chair: Rajneesh Nath, MD

02:15 PM – 02:45 PM  Myeloproliferative Neoplasms and CML - Jeanne Palmer, MD 

02:45 PM – 03:15 PM  Cellular Therapy - Muhammad Husnain, MD

03:15 PM – 03:30 PM  Break & Exhibits

03:30 PM – 04:30 PM  Session 6: Updates in Management of Breast Cancer

Session Chair: Sima Ehsani, MD

03:30 PM – 03:50 PM  HER2 Positive Breast Cancer

03:50 PM – 04:10 PM  Triple Negative and HER2 Low Breast Cancer

04:10 PM – 04:30 PM  ER/PR Positive Breast Cancer

04:30 PM – 05:20 PM  Session 7: Tumor Board Style Case-Based Discussion: Breast Cancer

Session Chair:

04:30 PM – 04:40 PM  Metaplastic Breast Cancer

04:40 PM – 04:50 PM  Low/Very Low HER2 Disease

04:50 PM – 05:00 PM  Surgery: Less is More

05:00 PM – 05:10 PM  Radiation: Keep it Simple

05:10 PM – 05:20 PM  DCIS

 05:20 PM  Adjourn

Sheraton Tucson Hotel & Suites
5151 E Grant Rd
Tucson, AZ 85712
United States

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

Session Chair(s)

Krishna Rekha Moturi

has no relevant financial relationships to disclose at this time.
Speaker/Topic Presenter(s)

Abhijeet Kumar

has a financial relationship (Other) with ADC therapeutics;.
has a financial relationship (Other) with AstraZeneca;.

Available Credit

  • 7.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 7.25 ACPE Pharmacy

    The Binaytara Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    The ACPE Universal Activity Number assigned to the activity is

    Participants must pass the post-test, complete course evaluation, and provide their NABP e-Profile ID number (ePID) and Date of Birth (MMDD) to Binaytara Foundation within 30-days of participating in the activity. Participants who do not complete these requirements within 30-days of participating in the Live activity will not be awarded the CEUs.

    The Binaytara foundation may distribute a participation certificate containing information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.

    After CPE units are processed by ACPE and NABP, pharmacists and pharmacy technicians will be able to login to a comprehensive electronic profile to access information about their completed CPE and Certificate Programs.

    ACPE Pharmacy
  • 7.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.

If you are interested in exhibiting at this meeting or purchasing a badge with your company at our discounted rate for exhibitors, please visit our exhibit page here - https://www.sponsorships.binaytara.org/TucsonHemeBreast

 

Price

Cost:
$150.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.